|Bid||75.47 x 800|
|Ask||75.48 x 900|
|Day's range||75.00 - 76.91|
|52-week range||68.44 - 91.40|
|Beta (5Y monthly)||0.42|
|PE ratio (TTM)||27.12|
|Earnings date||02 Feb 2022 - 07 Feb 2022|
|Forward dividend & yield||2.60 (3.45%)|
|Ex-dividend date||14 Sept 2021|
|1y target est||93.21|
Yahoo Finance's Anjalee Khemlani explains the latest on the Omicron variant, which has been detected in the United States.
The Yahoo Finance Live panel discusses the earnings reports from Salesforce, Allbirds, and HP Enterprise.
FDA grants priority review to AstraZeneca (AZN) and Merck's (MRK) sNDA for Lynparza for BRCA-mutated HER2-negative high-risk early breast cancer.